Clinical Trials at Carolina BioOncology Institute
As of August 2026, 15 paid clinical trials are recruiting at Carolina BioOncology Institute, located at 9801 KINCEY AVE, SUITE 145, HUNTERSVILLE, NC 28078-3110, phone (704) 947-6599 in Huntersville, North Carolina. Active studies at this site cover conditions such as Idiopathic Hypersomnia, Narcolepsy Type 2 and Narcolepsy Type 1. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
15 clinical trials at Carolina BioOncology Institute
·Clear filters·Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Study of XB010 in Subjects With Solid Tumors
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Phase 1 Study of ACR-2316 in Specific Advanced Solid Tumors
A Study to Assess the Adverse Events, Change in Disease Activity, and How Oral ABBV-711 Tablets Move Through the Body as a Monotherapy and in Combination With Intravenously Infused Budigalimab (ABBV-181), in Adults With Advanced Squamous Tumors
A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)
A Study of HS-20110 in Participants With Advanced Solid Tumors
GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors
A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells.
Open-Label, Dose-Escalation With Expansion to Assess the Safety, Tolerability, and PK of TRE-515 in Subjects With Solid Tumors
Common conditions studied in Huntersville
- Idiopathic Hypersomnia (7 active studies)
- Narcolepsy Type 2 (7 active studies)
- Narcolepsy Type 1 (6 active studies)
- Advanced Solid Tumor (5 active studies)
- Advanced Solid Tumors (5 active studies)
- Cervical Cancer (4 active studies)
Leading research sponsors in Huntersville
- NRG Oncology
- Takeda
- AbbVie
- Alkermes, Inc.
- Alliance for Clinical Trials in Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in Huntersville?
There are approximately 65 recruiting clinical trials in Huntersville, North Carolina listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Huntersville pay participants?
Most recruiting trials in Huntersville compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Huntersville?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Huntersville?
The most common conditions under active study in Huntersville include Idiopathic Hypersomnia (7), Narcolepsy Type 2 (7), Narcolepsy Type 1 (6), Advanced Solid Tumor (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Huntersville?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Huntersville on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Huntersville?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Huntersville?
Recruiting research sites in Huntersville include Carolina BioOncology Institute, Novant Health Cancer Institute - Huntersville, Levine Cancer Institute - Huntersville, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Huntersville right now?
The largest active categories in Huntersville are Cancer & tumors (33), Vaccines (1), HIV / STI (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Carolina BioOncology Institute?
Carolina BioOncology Institute is located at 9801 KINCEY AVE, SUITE 145, HUNTERSVILLE, NC 28078-3110. Use the Google Maps link in the intro above to get directions.
How do I contact Carolina BioOncology Institute?
You can reach Carolina BioOncology Institute by phone at (704) 947-6599. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.